Sanofi (SNY) Non Operating Income (2009 - 2016)

Sanofi has reported Non Operating Income for 8 years, with the latest figure at -$430.8 million in Q4 2016.

• Quarterly Non Operating Income fell 3.16% year-over-year to -$430.8 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$1.1 billion (down 42.67% YoY) and the FY2015 annual result came in at -$433.2 million, up 27.09% from the prior year.
• Non Operating Income declined to -$430.8 million in Q4 2016 per SNY's latest filing, from -$130.2 million in the prior quarter.
• Over five years, Non Operating Income peaked at -$104.1 million in Q1 2014 and troughed at -$430.8 million in Q4 2016.
• A 5-year average of -$213.1 million and a median of -$175.7 million in 2013 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2012 and 2014: Non Operating Income tumbled 176.77% in 2012, then jumped 54.25% in 2014.
• Over 5 years, Non Operating Income stood at -$421.5 million in 2012, then climbed by 10.55% to -$377.0 million in 2013, then jumped by 54.25% to -$172.5 million in 2014, then plunged by 142.13% to -$417.6 million in 2015, then declined by 3.16% to -$430.8 million in 2016.
• According to Business Quant data, Non Operating Income over the past three periods registered -$430.8 million, -$130.2 million, and -$417.6 million for Q4 2016, Q1 2016, and Q4 2015 respectively.